Kilele Health Inc.
Dayton, OH
- UEI
- YYQ9GCP29EA1
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 201 E Dixon Ave, Dayton, OH 45419, USA
- Website
- kilelehealth.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Initial animal validation of a multimodal molecular monitor for heart failure treatment - project summary recently the… | National Heart Lung and Blood Institute | $609,664 | |
| Sbir phase II: in-vivo validation of a volume-manufacturable and factory-calibrated wearable NT-probnp monitoring system… | National Science Foundation | $1,199,708 | |
| Sttr phase i: aptamer biosensors with the longevity and technology compatibility required for continuous biosensing… | National Science Foundation | $511,798 |
About Kilele Health Inc.
Kilele Health Inc. is a for-profit medical device company specializing in the development of innovative wearable biosensors for continuous health monitoring. Registered with SAM.gov since November 2021, the company focuses on creating advanced monitoring systems for cardiovascular diseases, particularly heart failure. Kilele Health's primary objective is to develop factory-calibrated continuous multi-modal molecular monitors that can revolutionize patient care and reduce healthcare costs. Their technology aims to provide real-time, remote monitoring of critical biomarkers, enabling more efficient and effective treatment management for chronic conditions.
Through federal grant awards, Kilele Health Inc. has secured funding for several groundbreaking projects. The National Heart, Lung, and Blood Institute (NHLBI) awarded the company a $234,209 Project Grant to develop and initially validate a multimodal molecular monitor for heart failure treatment. This project involves creating a skin-insertable sensor strip capable of continuously measuring biomarkers like NT-proBNP and potassium levels in heart failure patients. The National Science Foundation (NSF) has also supported Kilele Health's research, awarding a $999,758 Cooperative Agreement under its Technology, Innovation, and Partnerships program to develop and validate a wearable, continuous monitoring system for NT-proBNP. Additionally, the NSF provided a $511,798 Project Grant through its Small Business Technology Transfer (STTR) Phase I program to develop continuous diagnostic monitoring platforms beyond glucose sensing, utilizing electrochemical aptamer sensors. These projects aim to address limitations in current monitoring technologies, improve patient outcomes, reduce hospital readmissions, and optimize medication management in decentralized care settings.
Quick answers
What is Kilele Health Inc.'s UEI?
Kilele Health Inc.'s Unique Entity ID (UEI) in SAM.gov is YYQ9GCP29EA1.
Where is Kilele Health Inc. located?
Kilele Health Inc.'s physical address in SAM.gov is 201 E Dixon Ave, Dayton, OH 45419, USA.
Is Kilele Health Inc. registered in SAM.gov?
Yes. Kilele Health Inc.'s SAM.gov registration is active through September 4, 2027.
What is Kilele Health Inc.'s most recent federal award?
Kilele Health Inc.'s most recent federal grant award is Initial animal validation of a multimodal molecular monitor for heart failure treatment - project summary recently the… (R43HL174179), from National Heart Lung and Blood Institute, on May 1, 2024.
On GovTribe
See Kilele Health Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors